tradingkey.logo


tradingkey.logo


Myomo Inc

MYO
0.647USD
-0.034-4.98%
終倀 03/30, 16:00ET15分遅れの株䟡
21.55K時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Myomo Inc 䌁業名

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Incの䌁業情報


䌁業コヌドMYO
䌚瀟名Myomo Inc
䞊堎日Jun 12, 2017
最高経営責任者「CEO」Gudonis (Paul R)
埓業員数184
蚌刞皮類Ordinary Share
決算期末Jun 12
本瀟所圚地137 Portland Street
郜垂BOSTON
蚌刞取匕所NASDAQ OMX – NASDAQ Basic Amex
囜United States of America
郵䟿番号02114
電話番号16179969058
りェブサむトhttps://myomo.com/
䌁業コヌドMYO
䞊堎日Jun 12, 2017
最高経営責任者「CEO」Gudonis (Paul R)

Myomo Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.26M
+0.92%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
553.86K
+13.00%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
436.63K
+2.00%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+31.39%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
131.75K
+68.31%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.26M
+0.92%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
553.86K
+13.00%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
436.63K
+2.00%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+31.39%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
131.75K
+68.31%
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
事業別USD
䌚瀟名
収益
比率
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%

株䞻

曎新時刻: Thu, Feb 19
曎新時刻: Thu, Feb 19
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Rosalind Advisors, Inc.
9.97%
Herr Investment Group LLC
7.39%
Triple Gate Capital, LP
7.34%
Horton Capital Management LLC
5.09%
The Vanguard Group, Inc.
4.04%
他の
66.17%
株䞻統蚈
株䞻統蚈
比率
Rosalind Advisors, Inc.
9.97%
Herr Investment Group LLC
7.39%
Triple Gate Capital, LP
7.34%
Horton Capital Management LLC
5.09%
The Vanguard Group, Inc.
4.04%
他の
66.17%
皮類
株䞻統蚈
比率
Hedge Fund
23.98%
Investment Advisor
20.41%
Individual Investor
7.79%
Investment Advisor/Hedge Fund
7.69%
Research Firm
4.42%
Venture Capital
0.42%
Bank and Trust
0.14%
Pension Fund
0.12%
Family Office
0.04%
他の
34.99%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
169
22.12M
57.56%
-3.94M
2025Q3
153
21.95M
58.07%
-1.84M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
2023Q3
64
15.22M
79.76%
+6.49M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Rosalind Advisors, Inc.
3.79M
9.86%
+195.00K
+5.42%
Sep 30, 2025
Herr Investment Group LLC
2.85M
7.4%
+1.20M
+72.93%
Jun 30, 2024
Triple Gate Capital, LP
2.83M
7.35%
--
--
Mar 31, 2025
Horton Capital Management LLC
1.96M
5.1%
+1.96M
--
Dec 24, 2025
The Vanguard Group, Inc.
1.49M
3.86%
-2.94K
-0.20%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.50M
3.89%
-16.52K
-1.09%
Sep 30, 2025
Gudonis (Paul R)
1.25M
3.25%
-10.00K
-0.79%
Sep 09, 2025
Geode Capital Management, L.L.C.
804.43K
2.09%
+135.15K
+20.19%
Sep 30, 2025
UBS Financial Services, Inc.
208.79K
0.54%
+18.19K
+9.55%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
比率0.01%
ProShares Hedge Replication ETF
比率0%
iShares Russell 2000 ETF
比率0%
iShares Russell 2000 Growth ETF
比率0%
Global X Russell 2000 ETF
比率0%
Proshares Ultra Russell 2000
比率0%
ProShares UltraPro Russell2000
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™